Chin-Ting Huang

发表

Fast-forwarding hit to lead: aurora and epidermal growth factor receptor kinase inhibitor lead identification.

Santhosh Kumar Chittimalla, Yi-Hui Peng, H. Hsieh, 2010, Journal of medicinal chemistry.

Zika Virus NS3 Protease Pharmacophore Anchor Model and Drug Discovery

J. Hsu, Jinn-Moon Yang, Guann-Yi Yu, 2020, Scientific Reports.

Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitor.

H. Hsieh, C. Chen, Y. Chao, 2013, Journal of medicinal chemistry.

EGFR and myosin II inhibitors cooperate to suppress EGFR‐T790M‐mutant NSCLC cells

Y. Chao, J. Hsu, Chin-Ting Huang, 2012, Molecular oncology.

Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells.

T. Lien, D. Chou, Wen-Hsing Lin, 2011, Biochemical pharmacology.

Zika Virus NS3 Protease Pharmacophore Anchor Model and Drug Discovery

J. Hsu, Jinn-Moon Yang, Guann-Yi Yu, 2020, Scientific Reports.

Anchor-based classification and type-C inhibitors for tyrosine kinases

J. Hsu, Jinn-Moon Yang, Y. Chiu, 2015, Scientific Reports.

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer

C. Chen, Y. Chao, T. Yeh, 2014, PloS one.

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2

C. Chen, J. Hsu, Szu-Huei Wu, 2020, Antimicrobial Agents and Chemotherapy.

Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells.

T. Lien, D. Chou, Wen-Hsing Lin, 2011, Biochemical pharmacology.